Biogen to buy private U.K. company with chronic pain drug-Reuters

Biogen Idec Inc (BIIB.O) on Sunday said it would buy small, privately-held Convergence Pharmaceuticals to acquire the U.K.-based company's portfolio of experimental drugs for chronic nerve pain.

DealsNorth AmericaUSBriefs